Xiaoyan Michelle Zhang is Chief Scientific Officer of Ikena Oncology, Inc.. Currently has a direct ownership of 44,475 shares of IKNA, which is worth approximately $75,607. The most recent transaction as insider was on Jan 11, 2022, when has been sold 964 shares (Common Stock) at a price of $12.0 per share, resulting in proceeds of $11,568. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.5K
0% 3M change
0% 12M change
Total Value Held $75,607

Xiaoyan Michelle Zhang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 11 2022
SELL
Open market or private sale
$11,568 $12.0 p/Share
964 Reduced 2.12%
44,475 Common Stock
Jan 11 2022
BUY
Exercise of conversion of derivative security
$2,073 $2.15 p/Share
964 Added 2.08%
45,439 Common Stock
Jan 10 2022
SELL
Open market or private sale
$432 $12.0 p/Share
36 Reduced 0.08%
44,475 Common Stock
Jan 10 2022
BUY
Exercise of conversion of derivative security
$77 $2.15 p/Share
36 Added 0.08%
44,511 Common Stock
Dec 10 2021
SELL
Open market or private sale
$14,760 $14.76 p/Share
1,000 Reduced 2.2%
44,475 Common Stock
Dec 10 2021
BUY
Exercise of conversion of derivative security
$2,150 $2.15 p/Share
1,000 Added 2.15%
45,475 Common Stock
XMZ

Xiaoyan Michelle Zhang

Chief Scientific Officer
Boston, MA

Track Institutional and Insider Activities on IKNA

Follow Ikena Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IKNA shares.

Notify only if

Insider Trading

Get notified when an Ikena Oncology, Inc. insider buys or sells IKNA shares.

Notify only if

News

Receive news related to Ikena Oncology, Inc.

Track Activities on IKNA